Clinical Trials Logo

Anti-factor Xa clinical trials

View clinical trials related to Anti-factor Xa.

Filter by:
  • Completed  
  • Page 1

NCT ID: NCT03143569 Completed - Clinical trials for Gastro Intestinal Bleeding

Ventricular Assist Device Anti-Factor Xa (VAD ANTIX) Monitoring Study: a Prospective Randomized Feasibility Trial

VAD-ANTIX
Start date: May 20, 2017
Phase: N/A
Study type: Interventional

This study evaluates two different methods for monitoring a patient's anti-clotting [heparin] therapy after they receive a heart pump implant [left ventricular assist device -LVAD]. One method tests for how long it takes the patient's blood to clot and uses that to determine if they are on the right dose of heparin. The other method uses a more direct measure of how much heparin is in the blood. The hypothesis is that the method that more directly measures how much heparin is in the patient's blood will provide better medical results for the patient's care after they have the heart pump implant. To that end, the investigators are conducting this feasibility trial to establish the logistics associated with the implementation of these heparin monitoring approaches.